Abyrx
Stamford, US · 1 known investors
ABYRX develops synthetic, absorbable surgical biomaterials, including a bone hemostat used to stop bleeding on bone surfaces during surgery. Its products are tissue-free and designed to absorb after implantation for use in surgical and orthopedic procedures.
BiotechHealthtechMedical DevicesNew Materials
Investors · 1
In the news
Frequently asked questions
- What does Abyrx do?
- ABYRX develops synthetic, absorbable surgical biomaterials, including a bone hemostat used to stop bleeding on bone surfaces during surgery. Its products are tissue-free and designed to absorb after implantation for use in surgical and orthopedic procedures.
- Who are Abyrx's investors?
- Abyrx's investors include Canaan Partners.
- Where is Abyrx headquartered?
- Abyrx is headquartered in Stamford, US.